Portola Pharmaceuticals Inc. (PTLA) Declined -25.9% or -10.96 To Price $31.36 On Thursday


Portola Pharmaceuticals Inc. (PTLA) declined -25.9% or -10.96 to $31.36. It is approximately 8.80 million shares traded, which is 966.79% compare to the average total volume 910557. The market cap of PTLA is $2.05 billion. The year to date change is -13.21%. The 52 week price range is from $29.5 to $67.1. Price of PTLA have changed 0.47% during last week. It have changed -16.80% over last month, -7.52% over last 3 months, -24.47% over last 6 months and 28.95% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTLA is 49.08. It is 56.51% above current price. The 200-day Moving Averages for PTLA is 51.05. It is 62.79% above current price. The 52-week High is 67.1. It is 113.97% from the current price. The 52-week Low is 29.5. It is -5.93% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTLA is 5.68 on 2018-01-31. Short % to float is 7.59%. There are some statistics of PTLA. It is has market cap $2.05 billion. The share outstanding is 65.25 million. The average volume is 910557. The revenue is 26.44M. The gross profit is 3.67M. The percent of top 15 Institution holding is 85.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTLA is -74.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTLA is -52.28%.


Tags:

Share this post